Journey Medical Corp
DERM
Get informed when a big investor buys or sells
+ FollowMarket Cap$205.59M
Close$
$-5.57
171.7% downside
Current Fair Value
171.7% downsideOvervalued by 171.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $205.59 Million |
|---|---|
| Enterprise Value | $205.49 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.08 |
| Outstanding Shares | 27,493,693 |
Return
| Return on Equity | -19.01% |
|---|---|
| Return on Assets | -6.21% |
| Return on Invested Capital | -7.21% |
Valuation & Multiples
| P/E Ratio | -33.07 |
|---|---|
| PEG | 36.03 |
| Price to Sales | 3.89 |
| Price to Book Ratio | 7.77 |
| Enterprise Value to Revenue | 3.01 |
| Enterprise Value to EBIT | -54.19 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$18.36 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$21.89 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 28,400▲ Infinity% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 39.23%▼ 4.23% |
|---|---|
| Total Invested | $75.84M▲ 35.96% |
| Investors Holding | 74▲ 1.00% |
ESG Score
No data